A detailed history of Founders Capital Management transactions in Johnson & Johnson stock. As of the latest transaction made, Founders Capital Management holds 35,508 shares of JNJ stock, worth $5.17 Million. This represents 3.51% of its overall portfolio holdings.

Number of Shares
35,508
Previous 35,375 0.38%
Holding current value
$5.17 Million
Previous $5.17 Million 11.3%
% of portfolio
3.51%
Previous 3.36%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$145.48 - $167.38 $19,348 - $22,261
133 Added 0.38%
35,508 $5.75 Million
Q2 2024

Jul 10, 2024

BUY
$144.38 - $157.78 $2.4 Million - $2.62 Million
16,631 Added 88.73%
35,375 $5.17 Million
Q1 2024

Apr 10, 2024

SELL
$155.22 - $162.74 $155 - $162
-1 Reduced 0.01%
18,744 $2.97 Million
Q4 2023

Jan 08, 2024

SELL
$145.6 - $158.88 $51,251 - $55,925
-352 Reduced 1.84%
18,745 $2.94 Million
Q3 2023

Oct 10, 2023

BUY
$155.75 - $174.48 $130,830 - $146,563
840 Added 4.6%
19,097 $2.97 Million
Q2 2023

Jul 07, 2023

SELL
$154.35 - $166.11 $115,145 - $123,918
-746 Reduced 3.93%
18,257 $3.02 Million
Q1 2023

Apr 12, 2023

BUY
$151.05 - $180.26 $755 - $901
5 Added 0.03%
19,003 $2.95 Million
Q3 2022

Oct 06, 2022

SELL
$161.33 - $179.52 $26,942 - $29,979
-167 Reduced 0.87%
18,998 $3.1 Million
Q2 2022

Jul 20, 2022

SELL
$168.19 - $186.01 $128,328 - $141,925
-763 Reduced 3.83%
19,165 $3.4 Million
Q4 2021

Jan 21, 2022

BUY
$155.93 - $173.01 $1,559 - $1,730
10 Added 0.05%
19,928 $3.41 Million
Q3 2021

Oct 12, 2021

SELL
$161.5 - $179.47 $147,611 - $164,035
-914 Reduced 4.39%
19,918 $3.22 Million
Q2 2021

Jul 15, 2021

SELL
$159.48 - $171.07 $7,973 - $8,553
-50 Reduced 0.24%
20,832 $3.43 Million
Q1 2021

Jun 07, 2021

SELL
$153.07 - $170.48 $3,826 - $4,262
-25 Reduced 0.12%
20,882 $6,000
Q4 2020

Jan 12, 2021

BUY
$137.11 - $157.38 $781,252 - $896,751
5,698 Added 37.46%
20,907 $3.29 Million
Q1 2020

Apr 22, 2020

BUY
$111.14 - $153.99 $840,774 - $1.16 Million
7,565 Added 98.97%
15,209 $1.99 Million
Q4 2019

Jan 24, 2020

SELL
$127.5 - $146.44 $87,720 - $100,750
-688 Reduced 8.26%
7,644 $1.12 Million
Q4 2018

Jan 14, 2019

SELL
$122.84 - $147.84 $11,055 - $13,305
-90 Reduced 1.07%
8,332 $1.08 Million
Q3 2018

Oct 05, 2018

BUY
$121.58 - $142.88 $35,258 - $41,435
290 Added 3.57%
8,422 $1.16 Million
Q2 2018

Jul 09, 2018

SELL
$119.4 - $131.76 $6,686 - $7,378
-56 Reduced 0.68%
8,132 $987,000
Q1 2018

Apr 09, 2018

SELL
$125.1 - $148.14 $4,378 - $5,184
-35 Reduced 0.43%
8,188 $1.05 Million
Q4 2017

Jan 22, 2018

SELL
$131.22 - $143.62 $11,547 - $12,638
-88 Reduced 1.06%
8,223 $1.15 Million
Q3 2017

Oct 17, 2017

BUY
$129.47 - $135.38 $1.08 Million - $1.13 Million
8,311
8,311 $1.08 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Founders Capital Management Portfolio

Follow Founders Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Founders Capital Management with notifications on news.